# Study: Tirzepatide Results in Weight Loss for Individuals With Type 1 Diabetes ## Key Points: – In a recent study, tirzepatide has shown positive results in weight loss for individuals with type 1 diabetes. – Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. – The study included individuals with type 1 diabetes who were overweight or obese to evaluate the efficacy of tirzepatide for weight loss. – The results of the study suggest that tirzepatide could be a promising option for individuals with type 1 diabetes looking to manage their weight. ### Hot Take: The findings of this study on tirzepatide’s positive impact on weight loss for individuals with type 1 diabetes are promising. This could be a beneficial addition to the treatment options available for those looking to manage their weight effectively. Contact Mindful Evolution at https://yourmindfulevolution.com or call or text us at 954-639-9960. Weight Loss Disclaimer: Individual results may vary. Mindful Evolution offers telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia.